Key statistics
As of last trade, Hemogenyx Pharmaceuticals PLC (HEMO:LSE) traded at 1.65, 65.46% above the 52 week low of 1.00 set on Nov 14, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 1.75 |
---|---|
High | 1.80 |
Low | 1.60 |
Bid | 1.58 |
Offer | 1.68 |
Previous close | 1.53 |
Average volume | 20.57m |
---|---|
Shares outstanding | 1.40bn |
Free float | 1.26bn |
P/E (TTM) | -- |
Market cap | 21.38m GBP |
EPS (TTM) | -0.0042 GBP |
Data delayed at least 20 minutes, as of Nov 22 2024 09:03 GMT.
More ▼
- Institutional Investment
- Schedule for Phase I Clinical Trial Opening
- Strategic Investment from Prevail Partners, LLC
- Half-year Report
- FLT3 Assay Ready for Phase I Trials at MD Anderson
- CDX Development Update
- Presentation at CBD S&T Conference
- Macrophage-Directed Therapies Summit Presentation
- Result of Annual General Meeting
- Operations Update
More ▼